n-(2-hydroxypropyl)methacrylamide has been researched along with Leukemia L 1210 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duncan, R; Hume, IC; Kopecek, J; Kopecková, P; Lloyd, JB; Strohalm, J | 1 |
1 other study(ies) available for n-(2-hydroxypropyl)methacrylamide and Leukemia L 1210
| Article | Year |
|---|---|
Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia.
Topics: Acrylamides; Animals; Body Weight; Daunorubicin; Drug Carriers; Leukemia L1210; Male; Mice; Mice, Inbred DBA; Time Factors; Tissue Distribution | 1988 |